Finance

Lists
NUVB:NYSE
Nuvation Bio Inc
$ 4.71
-0.21%
(-0.0100) 1D
10-р сарын 14, 14:53:34 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUVB...
Open
$ 4.66
High
$ 4.80
Low
$ 4.61
Mkt. cap
1.65 тэрбум
Avg. vol.
5.45 сая
Volume
2.23 сая
52-wk high
$ 9.75
52-wk low
$ 3.36
EPS
-$ 0.44
Beta
1.61
Shares outstanding
351.12 сая
No. of employees
305
Open
$ 4.66
High
$ 4.80
Low
$ 4.61
Mkt. cap
1.65 тэрбум
Avg. vol.
5.45 сая
Volume
2.23 сая
52-wk high
$ 9.75
52-wk low
$ 3.36
EPS
-$ 0.44
Beta
1.61
Shares outstanding
351.12 сая
No. of employees
305
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
2 өдрийн өмнө
3 Penny Stocks With Revenue Growth Over 1%
About Nuvation Bio Inc
CEODavid Hung
Employees305
Founded2018
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 9 analysts giving stock ratings to NUVB in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NUVB in the last 3 months.
Highest
Current $ 4.71
$ 21.00 (+345.86%)
Average
$ 14.57 (+209.34%)
Lowest
$ 11.00 (+133.55%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Buy
Maintained
$ 20.00
+324.6%
10/12/2026
Geoff Meacham
Citi
Buy
Initiated
$ 12.00
+154.8%
10/01/2026
Priyanka Grover
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
David Nierengarten
Wedbush
Buy
Maintained
$ 11.00
+133.5%
09/15/2026
Gregory Renza
Truist Financial
Buy
Maintained
-
-
09/15/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
$ 12.00
+154.8%
08/21/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
$ 14.00
+197.2%
08/07/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$ 21.00
+345.9%
08/07/2026
Boris Peaker
JonesTrading
Buy
Reiterated
$ 12.00
+154.8%
08/06/2026
Yaron Werber
TD Cowen
Buy
Reiterated
-
-
06/01/2026
Soumit Roy
JonesTrading
Buy
Maintained
$ 12.00
+154.8%
04/06/2026
Michael Yee
UBS
Hold
Maintained
$ 7.00
+48.6%
03/03/2026
Last report
2026 оны 8-р сарын 6
Fiscal period
Q2 2026
-$ 0.15 / -$ 0.12
-25.15%miss
Revenue / Est. (USD)
31.69 сая / 28.70 сая
+10.42%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
13.12 сая
41.86 сая
83.23 сая
31.69 сая
Cost of goods sold
3.35 сая
1.28 сая
5.99 сая
9.47 сая
Cost of revenue
3.35 сая
1.28 сая
5.99 сая
9.47 сая
Research and development expenses
28.85 сая
34.30 сая
35.05 сая
30.66 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.36 сая
40.33 сая
38.31 сая
42.59 сая
Operating expense
66.20 сая
74.62 сая
73.36 сая
73.25 сая
Total operating expenses
69.55 сая
75.90 сая
79.35 сая
82.72 сая
Operating income
-56.43 сая
-34.04 сая
3.88 сая
-51.04 сая
Other non operating income
1.14 сая
-1.18 сая
3.11 сая
-179.00 мян
EBT including unusual items
-55.79 сая
-36.59 сая
5.40 сая
-62.84 сая
EBT excluding unusual items
-55.80 сая
-36.59 сая
5.39 сая
-53.38 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-55.79 сая
-36.59 сая
5.40 сая
-62.84 сая
Net profit margin
-425.24%
-87.40%
6.48%
-198.31%
Earnings per share
-0.14
-0.09
0.04
-0.15
Interest and investment income
6.03 сая
5.30 сая
5.11 сая
4.60 сая
Interest expense
-6.53 сая
-6.67 сая
-6.71 сая
-6.76 сая
Net interest expenses
-501.00 мян
-1.38 сая
-1.60 сая
-2.16 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-55.90 сая
-33.50 сая
4.42 сая
-50.50 сая
Gain or loss from assets sale
-4.00 мян
3.00 мян
-
-1.00 мян.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс